Search results - 6 results
Utilization of gabapentin by people in treatment for substance use disorders in Belgium (2011-2014): a cross-sectional study.
potential abuse. Results: Out of 30,905 patients in treatment for substance use disorders 2.7% had bought at least once gabapentin in a public pharmacy or received it from a hospital pharmacy, compared to 0.7% in ...
Activities in NPS & Data Sharing
Publication Type: Scientific poster, presentation or proceeding Authors: Eric Deconinck Source: CLEN meeting WG Data Sharing, JRC, Issue DG TAXUD European Commission and JRC, Brussels, Belgium ...
Quality and risk assessment of Illegal peptide drugs
Publication Type: Scientific poster, presentation or proceeding Authors: Steven Janvier Source: Tuesday Seminar, WIV-ISP, WIV-ISP (2017) Keywords: Illegal medicines Peptides Proteins Health Topics: ...
Registration of treatment demands for substance use disorders in Belgium: Why are some clients registered anonymously?
Publication Type: Scientific poster, presentation or proceeding Authors: Jérôme Antoine; Françoise Renard Source: Lisbon Addictions 2017 (2017) Health Topics: Illegale drugs Illicit drugs Drogues ...
Comparison between non-general practice patients and general practice patients treated for substance use problems
Publication Type: Scientific poster, presentation or proceeding Authors: Jérôme Antoine; Nicole Boffin; Karin De Ridder; L. Gremeaux; Viviane Van Casteren Source: Addictions Conference, Issue?, ...
Health care trajectories and medication consumption of substance users in treatment: linking TDI and IMA databases (Belgium)
Publication Type: Scientific poster, presentation or proceeding Authors: Karin De Ridder; Jérôme Antoine; L. Gremeaux; E Plettinckx; Peter Blanckaert; Jean Tafforeau Source: Methods in Epidemiology ...